MW
TEVA icon

Milestone Wealth’s Teva Pharmaceuticals TEVA Stock Holding History

Milestone Wealth’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$185K Buy
22,937
+7,000
+44% +$61.9K 0.21% 51
2022
Q2 		$120K Sell
15,937
-3,020
-16% -$26.3K 0.13% 73
2022
Q1 		$152K Hold
18,957
– – 0.12% 70
2021
Q4 		$152K Buy
+18,957
New +$171K 0.12% 70

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Milestone Wealth's TEVA Position: Q3 2022 in Review

Milestone Wealth increased its Teva Pharmaceuticals (TEVA) stake by 44% in Q3 2022, buying an estimated $61.9K and bringing the position to 22,937 shares worth $185K. The position accounts for 0.21% of the portfolio, ranked #51.

Milestone Wealth first reported a position in TEVA in Q4 2021 and has held it in 4 quarters since. 430 funds tracked by Wall St. Rank hold TEVA as of Q3 2022.

  • Milestone Wealth held 22,937 shares of Teva Pharmaceuticals worth $185K as of Q3 2022.
  • Milestone Wealth bought 7,000 Teva Pharmaceuticals shares in Q3 2022, an estimated $61.9K.
  • Teva Pharmaceuticals made up 0.21% of Milestone Wealth's portfolio in Q3 2022, its #51 holding.
  • Milestone Wealth first reported a position in Teva Pharmaceuticals in Q4 2021 and has held it in 4 quarters since.
  • 430 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2022.

Based on Milestone Wealth's 13F filing for Q3 2022, filed 14 Nov 2022.